Insulin glargine/lixisenatide vs Empagliflozin
National NHS prescribing compared (Prescription Cost Analysis)
Empagliflozin was dispensed 323,972.0× as often as Insulin glargine/lixisenatide in February 2026 — 323,972 items versus 1 in England.
1items
Insulin glargine/lixisenatide · February 2026
NHSBSA Prescription Cost Analysis
323,972items
Empagliflozin · February 2026
NHSBSA Prescription Cost Analysis
Figure 1. Insulin glargine/lixisenatide versus Empagliflozin: national items dispensed by month
▬ Insulin glargine/lixisenatide · ╌ Empagliflozin
Source: NHSBSA Prescription Cost Analysis, to February 2026
| Measure | Insulin glargine/lixisenatide | Empagliflozin |
|---|---|---|
| Items, February 2026 | 1 | 323,972 |
| Items, last 12 months | 139 | 4,615,976 |
| Net ingredient cost, February 2026 | £49 | £12,500,182 |
See the full profile for Insulin glargine/lixisenatide or Empagliflozin.